The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because of how widespread the medications are becoming. A 2024 study found that 12 ...

Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as ...

Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces ...

Semaglutide is the active ingredient in diabetes drug Ozempic and obesity medication ... and their benefits seem to extend beyond just weight loss. Just this month, for instance, a study of ...

Fresh questions are being asked about the use of weight loss ... weeks. Ozempic is only prescribed on the NHS for diabetes. The semaglutide drugs, manufactured by Novo Nordisk, saw global ...

Bloomberg/Getty Images One big area of concern for users of GLP-1 medications such as Ozempic and Wegovy is preventing muscle loss during weight loss. Salk Institute researchers have identified ...

Competition in the space is fierce, but shares got a much-needed boost on Friday after the Danish ... on the success of flagship weight-loss treatments Wegovy and Ozempic. Like those injections ...

Novo Nordisk hopes the new treatment can build on the success of its flagship obesity drug, Wegovy. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this ...

but shares got a much-needed boost on Friday after the Danish pharmaceutical giant released promising trial results for a next-generation drug that the company hopes will build on the success of ...